文献速递免疫规划

2008-2016年美国13-17岁青少年甲型肝炎疫苗接种覆盖率

Hepatitis A vaccination coverage among adolescents (13-17 years) in the United States, 2008-2016.
PubMed 文献 · Vaccine · 2018-02-12

利用2008-2016年美国全国青少年免疫调查数据,评估13-17岁青少年甲型肝炎疫苗1剂和≥2剂接种覆盖率及与接种启动相关的因素。2016年1剂和≥2剂覆盖率分别为73.9%和64.4%,接种启动与种族/族裔、军人支付来源和提供者推荐相关,而郊区或农村居住、贫困及缺乏州日托或学校甲肝要求与接种启动可能性降低相关。

要点

  • 2016年美国13-17岁青少年甲肝疫苗1剂覆盖率为73.9%,≥2剂为64.4%。
  • 1995年出生至2003年出生青少年甲肝疫苗接种覆盖率全国增加40个百分点。
  • 提供者推荐甲肝疫苗接种与接种启动增加独立相关(2008-2013年)。

核心结论

  • 在全国所有地区增加青少年甲肝疫苗覆盖率的努力将加强人群对甲型肝炎病毒的保护。

研究设计与样本

  • 利用2008-2016年美国全国青少年免疫调查评估13-17岁青少年甲肝疫苗1剂和≥2剂接种覆盖率。
  • 通过双变量和多变量分析确定与甲肝疫苗系列启动(1剂)相关的因素。
  • 数据按ACIP推荐州分组分层:1999年起推荐普遍儿童接种(第1组)、1999年起考虑儿童接种(第2组)、2006年起推荐普遍儿童接种(第3组)。

主要发现

  • 2016年全国13-17岁青少年甲肝疫苗1剂和≥2剂接种覆盖率分别为73.9%和64.4%。
  • 全国范围内,2003年出生青少年相比1995年出生青少年疫苗接种覆盖率增加40个百分点。
  • 全国范围内,与疫苗启动增加独立相关的因素为种族/族裔(西班牙裔、美洲印第安人/阿拉斯加原住民、亚洲人)、军人支付来源和提供者推荐甲肝疫苗接种(2008-2013年)。
  • 居住于郊区或农村地区、贫困(水平<1.33-5.03)以及缺乏州日托或学校甲肝要求是与疫苗启动可能性降低相关的常见因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The hepatitis A (HepA) vaccine was recommended by the Advisory Committee on Immunization Practices (ACIP) incrementally from 1996 to 1999. In 2006, HepA vaccine was recommended (1) universally for children aged 12-23 months, (2) for persons who are at increased risk for infection, or (3) for any person wishing to obtain immunity. Catch-up vaccination can be considered. OBJECTIVE: To assess HepA vaccine coverage among adolescents and factors independently associated with vaccination administration in the US. METHODS: The 2008-2016 National Immunization Survey-Teen was utilized to determine 1 and ≥2 dose HepA vaccination coverage among adolescents aged 13-17 years. Factors associated with HepA vaccine series initiation (1 dose) were determined by bivariate and multivariable analyses. Data were stratified by state groups based on ACIP recommendation: universal child vaccination recommended since 1999 (group 1); child vaccination considered since 1999 (group 2); universal child vaccination recommendation since 2006 (group 3). RESULTS: In 2016, national vaccination coverage for 1 and ≥2 doses of HepA vaccine among adolescents was 73.9% and 64.4%, respectively. Nationally, a 40 percentage point increase in vaccination coverage occurred among adolescents born in 1995 compared to adolescents born in 2003. Nationally, the independent factors associated with increased vaccine initiation was race/ethnicity (Hispanic, American Indian/Alaskan Native, Asian), military payment source and provider recommendation for HepA vaccination (2008-2013). Living in a suburban or rural region, living in poverty (level <1.33-5.03), and absence of state daycare or school HepA requirement were common factors associated with decreased likelihood of vaccine initiation. CONCLUSIONS: Efforts to increase HepA vaccine coverage in adolescents in all regions of the country would strengthen population protection from hepatitis A virus (HAV).

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Nelson NP, Yankey D, Singleton JA, et al. Hepatitis A vaccination coverage among adolescents (13-17 years) in the United States, 2008-2016. Vaccine. 2018. PMID: 29449100. doi:10.1016/j.vaccine.2018.01.090

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。